Sea Otter Advisors’s Estrella Immunopharma ESLA Stock Holding History

Sea Otter Advisors’s Portfolio ESLA Stock Details ESLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14,026	Closed	-$152K	–	263
2023 Q2	$152K	Hold	14,026	–	–	0.08%	106
2023 Q1	$148K	Buy	+14,026	New	+$147K	0.08%	133
2022 Q4	–	Sell	-21,000	Closed	-$211K	–	77
2022 Q3	$211K	Buy	+21,000	New	+$211K	0.44%	45

Other funds holding ESLA

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Sea Otter Advisors's ESLA Position: Q3 2023 in Review

Sea Otter Advisors sold out of Estrella Immunopharma (ESLA) in Q3 2023, closing a stake of 14,026 shares — an estimated $152K sold.

Sea Otter Advisors first reported a position in ESLA in Q3 2022 and held it in 3 quarters. The position peaked at $211K in Q3 2022. 3 funds tracked by Wall St. Rank hold ESLA as of Q3 2023.

Sea Otter Advisors reported no remaining Estrella Immunopharma position as of Q3 2023 after selling out during the quarter.
Sea Otter Advisors sold 14,026 Estrella Immunopharma shares in Q3 2023, an estimated $152K.
Sea Otter Advisors first reported a position in Estrella Immunopharma in Q3 2022 and held it in 3 quarters.
Sea Otter Advisors's Estrella Immunopharma position peaked at $211K in Q3 2022.
3 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q3 2023.

Based on Sea Otter Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.